Chemical Structure (Vancomycin 01)
Vancomycin Hydrochloride
Product Images NDC 72572-805
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vancomycin Hydrochloride (NDC 72572-805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (5 gram Bottle Carton)
This text is describing the use of Vancomycin hydrochloride injection after reconstitution and further dilution. The product is intended for intravenous use only and must be dispensed using a suitable dispensing set and aseptic technique. It is important to read the package insert for precautions and directions for use before administration. The product must be discarded no later than 4 hours after initial entry. The usual adult dosage is 2g daily, divided into doses. Prior to reconstitution, the product must be stored at a controlled room temperature between 20°C to 25°C. The vial stoppers do not contain natural rubber latex. The text also provides some information about the manufacturer of the product.*
Principal Display Panel (10 gram Bottle Carton)
This is a medication called Vancomycin Hydrochloride for Injection that is used for intravenous use after dilution. It comes in a Pharmacy Bulk Package that must be further diluted before use. The package insert has precautions and directions for use that must be read before use. The 5mL and 10mL solutions have different concentrations of the medication. The bottling should be discarded within 4 hours after initial entry. The medication should be used promptly after reconstitution. The usual adult dosage is 2 g daily, in divided doses. This medication is produced in Denmark by Xelia Pharmaceuticals ApS for Civica, Inc in Lehi, Utah.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
